HSD17B13 and hepatocellular carcinoma: As displayed in Fig. 4c-e, overexpression of SPP2, LECT2, SLC10A1, CYP3A4, HSD17B13, and IYD differentially suppressed HCC glycolytic capacity as demonstrated by reduced glucose uptake, lactate release, and ECAR.